Ultralife (ULBI) Current Deferred Revenue (2010 - 2012)

Ultralife's Current Deferred Revenue history runs 3 years deep, the most recent figure standing at $1.9 million for Q4 2012.

• In Q4 2012, Current Deferred Revenue rose 3.64% year-over-year to $1.9 million; the TTM figure through Dec 2012 stood at $1.9 million (up 3.64% YoY), while the FY2012 annual figure was $1.9 million, up 3.64% from the prior year.
• Current Deferred Revenue was $1.9 million for Q4 2012 at Ultralife, up from $1.8 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $2.9 million in Q4 2010 to a low of $1.8 million in Q4 2011.
• Historically, Current Deferred Revenue has averaged $2.2 million across 3 years, with a median of $1.9 million in 2012.
• The sharpest annual moves came in 2011 and 2012: Current Deferred Revenue tumbled 38.14% in 2011, then grew 3.64% in 2012.
• A 3-year view of Current Deferred Revenue shows it stood at $2.9 million in 2010, then sank by 38.14% to $1.8 million in 2011, then grew by 3.64% to $1.9 million in 2012.
• The last three Current Deferred Revenue figures came in at $1.9 million (Q4 2012), $1.8 million (Q4 2011), and $2.9 million (Q4 2010), per Business Quant data.